Combination hyperbaric oxygen and temozolomide therapy in c6 rat glioma model;Terapia combinada de oxigênio hiperbárico e temozomida no modelo C6 de glioma em ratos

Acta Cirurgica Brasileira

Volumn 27, Issue 6, 2012, Pages 383-387

  Dagistan, Yaşar ^a   Karaca, Ismail ^b   Bozkurt, Erol Ruştu ^c   Ozar, Engin ^b   Yagmurlu, Kaan ^b   Toklu, Akin ^d   Bilir, Ayhan ^d  

^a Izzet Baysal Hospital   (Turkey)

^b 1st Neurosurgery Clinic in Bakirkoy Mental Diseases Hospital   (Turkey)

^c Abdurrahman Nafiz Gurman Street Kocamustafapasa ^*  (Turkey)

^d ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Glioblastoma; Glioma; Hyperbaric Oxygenation; Rats; Temozolomide

Indexed keywords

GREEN FLUORESCENT PROTEIN; KI 67 ANTIGEN; TEMOZOLOMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLIOMA; HYPERBARIC OXYGEN; IMMUNOHISTOCHEMISTRY; NONHUMAN; RAT; TREATMENT OUTCOME; TUMOR NECROSIS; TUMOR VOLUME;

EID: 84862002755     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/S0102-86502012000600005     Document Type: Article

References (22)

1. Benítez JA, Domínguez-Monzón G, Segovia J. Conventional and gene therapy strategies for the treatment of brain tumors. Curr Med Chem. 2008;15(8):729-42.
2. Attenello FJ, Mukherjee D, Datoo G, McGirt MJ, Bohan E, Weingart JD, Olivi A, Quinones-Hinojosa A, Brem H. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience. Ann Surg Oncol. 2008;15(10):2887-93.
3. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008;359(5):492-507.
4. Combs SE, Wagner J, Bischof M, Welzel T, Edler L, Rausch R, Wagner F, Zabel-du Bois A, Debus J, Schulz-Ertner D. Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens. Int J Radiat Oncol Biol Phys. 2008;71(4):999-1005.
5. Chang SM, Lamborn KR, Malec M, Larson D, Wara W, Sneed P, Rabbitt J, Page M, Nicholas MK, Prados MD. Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2004;60(2):353-7.
6. Tentori L, Leonetti C, Aquino A. Temozolomide reduces the metastatic potential of Lewis lung carcinoma (3LL) in mice: role of alpha-6 integrin phosphorylation. Eur J Cancer. 1995;31A(5):746-54.
7. Khan N, Li H, Hou H, Lariviere JP, Gladstone DJ, Demidenko E, Swartz HM. Tissue pO2 of orthotopic 9L and C6 gliomas and tumor-specific response to radiotherapy and hyperoxygenation. Int J Radiat Oncol Biol Phys. 2009;73(3):878-85.
8. Sheehan J, Sherman J, Cifarelli C, Jagannathan J, Dassoulas K, Olson C, Rainey J, Han S. Effect of trans sodium crocetinate on brain tumor oxygenation. Laboratory investigation. J Neurosurg. 2009;111(2):226-9.
9. Chang CH. Hyperbaric oxygen and radiation therapy in the management of glioblastoma. Natl Cancer Inst Monogr. 1977;46:163-9.
10. Dowling S, Fischer JJ, Rockwell S. Fluosol and hyperbaric oxygen as an adjunct to radiation therapy in the treatment of malignant gliomas: a pilot study. Biomater Artif Cells Immobilization Biotechnol. 1992;20(2-4):903-5.
11. Al-Waili NS, Butler GJ, Beale J, Hamilton RW, Lee BY, Lucas P. Hyperbaric oxygen and malignancies: a potential role in radiotherapy, chemotherapy, tumor surgery and phototherapy. Med Sci Monit. 2005;11(9):RA279-89.
12. Chang SM, Lamborn KR, Malec M, Larson D, Wara W, Sneed P, Rabbitt J, Page M, Nicholas MK, Prados MD. Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2004;60(2):353-7.
13. Payne MJ, Pratap SE, Middleton MR. Temozolamide in the treatment of solid tumours: current results and rationale for dosing/scheduling. Crit Rev Oncol Hematol. 2005;53(3):241-52.
14. Plowman J, Waud WR, Koutsoukos AD, Rubinstein LV, Moore TD, Grever MR. Preclinical antitumor activity of temozolomide in mice: efficacy againsthuman brain tumor xenografts and synergism with 1, 3-bis (2-chloroethyl)-1-nitrosourea. Cancer Res. 1994;54(14):3793-9.
15. Son MJ, Kim JS, Kim MH, Song HS, Kim JT, Kim H, Shin T, Jeon HJ, Lee DS, Park SY, Kim YJ, Kim JH, Nam DH. Combination treatment with temozolomide and thalidomide inhibits tumor growth and angiogenesis in an orthotopic glioma model. Int J Oncol. 2006;28(1):53-9.
16. Kang SG, Kim JS, Park K, Kim JS, Groves MD, Nam DH. Combination celecoxib and temozolomide in C6 rat glioma orthotopic model. Oncol Rep. 2006;15(1):7-13.
17. Daruwalla J, Christophi C. Hyperbaric oxygen therapy for malignancy: a review. World J Surg. 2006;30(12):2112-31.
18. Kayama T, Yoshimoto T, Fujimoto S, Sakurai Y. Intratumoral oxygen pressure in malignant brain tumor. J Neurosurg. 1991;74(1):55-9.
19. Spence AM, Muzi M, Swanson KR, O'Sullivan F, Rockhill JK, Rajendran JG, Adamsen TC, Link JM, Swanson PE, Yagle KJ, Rostomily RC, Silbergeld DL, Krohn KA. Regional hypoxia in glioblastoma multiforme quantified with [18F] fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival. Clin Cancer Res. 2008;14(9):2623-30.
20. Kohshi K, Kinoshita Y, Imada H, Kunugita N, Abe H, Terashima H, Tokui N, Uemura S. Effects of radiotherapy after hyperbaric oxygenation on malignant gliomas. Br J Cancer. 1999;80(1-2):236-41.
21. Stuhr LB, Raa A, Øyan AM, Kalland KH, Sakariassen PO, Petersen K, Bjerkvig R, Reed RK. Hyperoxia retards growth and induces apoptosis, changes in vascular density and gene expression in transplanted gliomas in nude rats. J Neurooncology. 2007;85(2):191-202.
22. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182 (3):311-22.